Visual Representations of Gender and Computing in Consumer and Professional Magazines

Studies in the nineteen-eighties showed that advertising images of computers were gendered, with women relatively less represented, and shown with less empowered roles, problems or presented as sexual objects. This paper uses a mix of content and interpretative analysis to analyse current imagery in consumerist and professional society publications. It reveals the present variation and complexity of the iconography of computers and people across different domains of representation, with the continuation of gender bias in subtle forms

Quasar candidate selection and photometric redshift estimation based on SDSS and UKIDSS data

We present a sample of 8498 quasars with both SDSS $ugriz$ optical and UKIDSS $YJHK$ near-IR photometric data. With this sample, we obtain the median colour-z relations based on 7400 quasars with magnitude uncertainties less than 0.1mag in all bands. By analyzing the quasar colours, we propose an empirical criterion in the $Y-K$ vs. $g-z$ colour-colour diagram to separate stars and quasars with redshift $z<4$, and two other criteria for selecting high-z quasars. Using the SDSS-UKIDSS colour-z relations, we estimate the photometric redshifts of 8498 SDSS-UKIDSS quasars, and find that 85.0% of them are consistent with the spectroscopic redshifts within $|\Delta z|<0.2$, which leads to a significant increase of the photometric redshift accuracy than that based on the SDSS colour-z relations only. We compare our colour selection criterion with a small UKIDSS/EDR quasar/star sample and a sample of 4671 variable sources in the SDSS Stripe 82 region with both SDSS and UKIDSS data, and find that they can be clearly divided into two classes (quasars and stars) by our criterion in the $Y-K$ vs. $g-z$ plot. We select 3834 quasar candidates from the variable sources with $g<20.5$ in Stripe 82, 826 of them being SDSS quasars and the rest without SDSS spectroscopy. We demonstrate that even at the same spectroscopy limit as SDSS, with our criterion we can at least partially recover the missing quasars with $z\sim2.7$ in SDSS. The SDSS identified quasars only take a small fraction (21.5%) of our quasar candidates selected from the variable sources in Stripe 82, indicating that a deeper spectroscopy is very promising in producing a larger sample of quasars than SDSS. The implications of our results to the future Chinese LAMOST quasar survey are also discussed.Comment: 13 pages, 13 figures, 2 tables, accepted for publication in MNRA

Life in the Atacama — Year 2: Geologic reconnaissance through long-range roving and implications on the search for life

The Life in the Atacama-2004 project, which included geological, morphological, and mineralogical mapping through combined satellite, field-based, and microscopic perspectives and long-range roving, led to the localization of potential habitats

Spectroscopic results from the Life in the Atacama (LITA) project 2004 field season

Analysis of spectroscopy datasets from rover field tests in the Atacama Desert (Chile), focusing on the composition of the surface and identification of potential habitats for life

Searching for life with rovers: exploration methods and science results from the 2004 field campaign of the “Life in the Atacama” project and applications to future Mars Missions

LITA develops and field tests a long-range automated rover and a science payload to search for microbial life in the Atacama. The Atacama's evolution provides a unique training ground for designing and testing exploration strategies and life detection methods for the search for life on Mars

Use of a novel rover-mounted fluorescence imager and fluorescent probes to detect biological material in the Atacama Desert in daylight

We deployed our fluorescence imaging system which detects fluorescence signals from sparse microorganisms and biofilms on Carnegie Mellon University’s autonomous rover Zoë. The results of the 2004 Atacama Desert field season, in Chile, are discussed

Effect of daily chlorhexidine bathing on hospital-acquired infection

BACKGROUND Results of previous single-center, observational studies suggest that daily bathing of patients with chlorhexidine may prevent hospital-acquired bloodstream infections and the acquisition of multidrug-resistant organisms (MDROs). METHODS We conducted a multicenter, cluster-randomized, nonblinded crossover trial to evaluate the effect of daily bathing with chlorhexidine-impregnated washcloths on the acquisition of MDROs and the incidence of hospital-acquired bloodstream infections. Nine intensive care and bone marrow transplantation units in six hospitals were randomly assigned to bathe patients either with no-rinse 2% chlorhexidine– impregnated washcloths or with nonantimicrobial washcloths for a 6-month period, exchanged for the alternate product during the subsequent 6 months. The incidence rates of acquisition of MDROs and the rates of hospital-acquired bloodstream infections were compared between the two periods by means of Poisson regression analysis. RESULTS A total of 7727 patients were enrolled during the study. The overall rate of MDRO acquisition was 5.10 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient-days with nonantimicrobial washcloths (P=0.03), the equivalent of a 23% lower rate with chlorhexidine bathing. The overall rate of hospital-acquired bloodstream infections was 4.78 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient-days with nonantimicrobial washcloths (P=0.007), a 28% lower rate with chlorhexidine-impregnated washcloths. No serious skin reactions were noted during either study period. CONCLUSIONS Daily bathing with chlorhexidine-impregnated washcloths significantly reduced the risks of acquisition of MDROs and development of hospital-acquired bloodstream infections. (Funded by the Centers for Disease Control and Prevention and Sage Products; ClinicalTrials.gov number, NCT00502476.

Implementation of a daylight fluorescence imaging system to autonomously detect biomarkers of extant life in the Atacama Desert

We have integrated a biomarker detection system with a rover for the search for sparse life in extreme environments. The system incorporated a pulsed fluorescence imager, a reagent sprayer, and a surface scraping device for remote detection of fluorescence signals

Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early‐stage hepatocellular carcinoma: An analysis of SEER‐medicare

IntroductionFor early‐stage hepatocellular carcinoma (HCC) patients, ablative strategies are potentially curative treatment options. Stereotactic body radiotherapy (SBRT) has emerged as a promising ablative therapy, although its comparison with radiofrequency ablation (RFA) remains confined to a single institution retrospective review. We sought to characterize the comparative outcomes and cost between the two treatment strategies.MethodsWe conducted a secondary analysis of the Surveillance, Epidemiology, and End Results (SEER)‐Medicare linked database (2004–2011) and identified adult patients with stage I or II HCC and treated with RFA or SBRT as the initial treatment within 6 months of diagnosis. Survival analysis was conducted using Kaplan–Meier curves and multivariate Cox proportional hazard analysis. Factors associated with overall survival and 90‐day hospital admission post‐treatment were identified using propensity score (PS) adjusted multivariate analysis. We performed costs analysis and calculated incremental cost‐effectiveness ratios (ICER).ResultsFour hundred and forty patients were identified, 408 treated with RFA and 32 SBRT. In the overall cohort, 90‐day hospitalization and 1‐year mortality were similar between groups but RFA patients had better overall survival (P < 0.001). Multivariate analysis showed advanced age, higher stage, decompensated cirrhosis, and treatment with SBRT (HR 1.80; 95%CI: 1.15–2.82) was associated with worse survival, but in the PS adjusted analysis, survival and costs were similar between the two groups.ConclusionIn a national cohort of early stage HCC patients, treatment with RFA vs SBRT resulted in no significant difference in survival, 90‐day hospitalization, or costs. These data highlight the need for a randomized clinical trial comparing these two modalities.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/146355/1/jmiro12754_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/146355/2/jmiro12754.pd